U.S. drugmaker Pfizer Inc and Ireland-based Allergan Plc walked away from their $160 billion merger on Wednesday, a major win for President Barack Obama, who has been pushing to curb deals in which companies move overseas to save on taxes.
Pfizer said the decision was driven by new U.S. Treasury rules aimed at curbing such deals, called inversions. The merger would have allowed New York-based Pfizer to cut its tax bill by an estimated $1 billion annually by domiciling in Ireland, where tax rates are lower.
01:02 A company Trump attacked will receive state tax breaks to keep jobs in the U.S13
16:37 Boeing Received Illegal Tax Subsidy for 777X, WTO Panel Says13
14:49 Trump warns of ‘retribution’ for companies that offshore jobs, threatening 35 percent tariff13
20:37 Brazil grants antitrust approval for FMC Technologies, Technip merger18